By Drug Target Review2024-09-09T12:00:58
The study’s findings could contribute to future therapeutic strategies to prevent chronic kidney disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-02-13T11:57:11
Sponsored by Agilent
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-03-23T14:46:21
Sponsored by Bio-Techne
Site powered by Webvision Cloud